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Introduction 
EPE  is  a  chemically  (2RS)-1-(4-Ethylphenyl)-2-
methyl-3-piperidin-1-ylpropan-1-one  monohydrochlo-
ride  (1:1)  (Figure  1).  EPE  is  a  new  generation 
antispasmodic  drug.
1  It  exhibits  both  skeletal  muscle 
relaxant  and  vasodilator  properties  because  of  its 
actions  within  the  central  nervous  system  and  on 
vascular smooth muscles and demonstrates a variety of 
pharmacological  effects  such  as  cervical  spondylosis, 
headache  and  low  back  pain.
2  EPE  is  official  in 
Japanese  Pharmacopeia  and  described  potentiometric 
method  for  its  estimation.
3  Literature  survey  divulge 
that ESI-MS method for estimation of EPE in human 
plasma,
4  HPLC/MS,  GC/MS,  NMR,  UV  and  IR 
analytical techniques to identify a degradation product 
of EPE in the tablets dosage form
5 are available. More 
recently  spectrophotometric  method  for  simultaneous 
estimation of EPE and Diclofenac sodium in synthetic 
mixture has been reported.
6 
PAR is a chemically N-(4-Hydroxyphenyl)  acetamide 
(Figure  1).  PAR  is  a  non-opioid,  non-salicylate 
analgesic with an unclear mechanism of action. PAR is 
official in IP,
7 BP
8 and USP.
9 Literature survey reveals 
U.V.  and  chromatographic  methods  are  available  for 
estimation  of  PAR  in  single  and  combined  dosage 
forms.
10-17 Literature survey also reveals LC-MS, GC-
MS,  IR
18  and  HPTLC
19  methods  are  reported  for 
estimation of PAR with other drugs in combination. 
EPE  is  a  potent  new  generation  antispasmodic  drug 
which is used in the treatment of moderate to severe 
pain  in  combination  with  PAR.  Literature  survey 
reveals that no method has been reported for estimation 
of EPE and PAR in combination. The objective of the 
present  work  is  to  develop  new  spectrophotometric 
method  for  estimation  of  EPE  and  PAR  in  tablet 
formulation  with  good  accuracy,  simplicity,  precision 
and economy over other chromatographic methods and 
which can be used for routine analysis. 
 
 
Figure 1. Structure of EPE and PAR 
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Purpose: Eperisone Hydrochloride (EPE) is a potent new generation antispasmodic 
drug which is used in the treatment of moderate to severe pain in combination with 
Paracetamol (PAR). Both drugs are available in tablet dosage form in combination 
with a dose of 50 mg for EPE and 325 mg PAR respectively. Methods: The method is 
based upon Q-absorption ratio method for the simultaneous determination of the EPE 
and  PAR.  Absorption  ratio  method  is  used  for  the  ratio  of  the  absorption  at  two 
selected wavelength one of which is the iso-absorptive point and other being the λmax 
of one of the two components. EPE and PAR shows their iso-absorptive point at 260 
nm in methanol, the second wavelength used is 249 nm which is the λmax of PAR in 
methanol.  Results:  The  linearity  was  obtained  in  the  concentration  range  of  5-25 
μg/mL  for  EPE  and  2-10  μg/mL  for  PAR.  The  proposed  method  was  effectively 
applied  to  tablet  dosage  form  for  estimation  of  both  drugs.  The  accuracy  and 
reproducibility results are close to 100% with 2% RSD. Results of the analysis were 
validated statistically and found to be satisfactory. The results of proposed method 
have  been  validated  as  per  ICH  guidelines.  Conclusion:  A  simple,  precise  and 
economical spectrophotometric method has been developed for the estimation of EPE 
and PAR in pharmaceutical formulation.  
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Materials and Methods  
The instrument used in the present study was JASCO 
double beam UV/Visible Spectrophotometer (Model V-
630) with  spectral bandwidth  of  1 nm  and 10  mm  a 
matched quartz cell was used. All weighing was done 
on electronic balance (Model Shimadzu BL 320-H). 
 
Reagents and Chemicals  
Analytically  pure  sample  of  EPE  and  PAR  were 
obtained as a gift sample from Abbott Healthcare pvt. 
Ltd., Mumbai, India and Wockhardt Ltd., Aurangabad, 
India  respectively.  The  analytical  reagent  grade 
methanol acquired from Loba Chemie, Mumbai, India 
and used as solvent. Marketed preparation of EPE and 
PAR was procured from local market.  
 
Preparation of Stock Standard Solutions 
Stock  standard  solutions  of  EPE  and  PAR  were 
prepared  separately  by  dissolving  10  mg  in  100  mL 
methanol to obtain concentration 100 μg/mL of each. 
From these stock solutions, working standard solutions 
having concentration 10 μg/mL of EPE and 10 μg/mL 
of PAR were prepared by proper dilutions. They were 
scanned in the UV region i.e. 400-200 nm. The overlain 
spectrum  (Figure  2)  was  obtained  to  determine  the 
maximum absorbance (λ max) and iso-absorptive point. 
 
 
Figure 2. Overlain absorption spectra of EPE (10 μg/mL) and 
PAR (10 μg/mL) in methanol. 
 
Estimation  of  EPE  and  PAR  from  Pharmaceutical 
Formulation by Q-Absorbance Ratio Method
20 
Q-Absorbance method uses the ratio of absorbance at 
two selected wavelengths, one at iso-absorptive point 
and other being the λ max of one of the two drugs. The 
content of twenty tablets were accurately weighed and 
crushed  into  fine  powdered.  A  quantity  of  powder 
equivalent to 5 mg of EPE and 32.5 mg of PAR was 
transferred to 100 mL volumetric flask containing 60 
mL  methanol,  shaken  manually  for  20  min  and  the 
volume was made up to the mark and filtered through 
whatmann filter paper (no.41). The solution was further 
diluted with methanol to give the concentration within 
Beer’s  Law  range.  Absorbance  of  this  solution  was 
measured at 249 nm and 260 nm and concentrations of 
these  two  drugs  in  the  tablet  formulation  were 
calculated using equation (1) and equation (2).  
The  concentration  of  two  drugs  in  mixture  was 
calculated by using following equations: 
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‘A’, is the absorbance of mixture at 260 nm and ax1, 
ax2 and ay1, ay2 are E (1%, 1 cm) of EPE and PAR at 
260 nm and 249 nm and Qm= A2/A1, Qy = ay2/ay1 
and Qx = ax2/ax1. 
 
Method Validation  
Validation of proposed method was done as per ICH 
guidelines
21 by means of the following parameters. 
 
Linearity  
As  per  ICH  guidelines  the  linearity  of  an  analytical 
procedure is its ability (within a given range) to obtain 
test  results  which  are  directly  proportional  to  the 
concentration (amount) of analyte in the sample.
21 An 
appropriate volume of EPE and PAR in the range of 
0.5-2.5  mL  and  0.2-1.0  mL  respectively  were 
transferred  into  series  of  separate  10  mL  volumetric 
flasks and volume was made up to mark with methanol 
to get concentrations in the range of 5–25 μg/mL and 2-
10 μg/mL respectively.  
 
Accuracy and Precision 
The accuracy of an analytical procedure expresses the 
closeness  of  agreement  between  the  value  which  is 
accepted  either  as  a  conventional  true  value  or  an 
accepted  reference  value  and  the  value  found.  The 
precision  of  an  analytical  procedure  expresses  the 
closeness of  agreement (degree  of scatter)  between  a 
series  of  measurements  obtained  from  multiple 
sampling of the same homogeneous sample under the 
prescribed conditions.
21 The accuracy of the proposed 
methods was checked by recovery studies, by addition 
of standard drug solution to reanalyzed sample solution 
at three different concentration levels within the range 
of  linearity  for  both  the  drugs.  The  precision  of  the 
analytical  method  was  checked  by  repeated  scanning 
and measurement of absorbance of solutions (n=5) for 
EPE  and  PAR  (5  μg/mL  for  both  drugs)  without 
changing  the  parameter  of  the  proposed 
spectrophotometry method.  
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Specificity 
Specificity  is  the  ability  to  assess  unequivocally  the 
analyte in the presence of components which may be 
expected to be present.
21 Typically these might include 
impurities, degradants, 
matrix, etc. 
 
Limit of Detection 
According to ICH guidelines the detection limit of an 
individual analytical procedure is the lowest amount of 
analyte  in  a  sample  which  can  be  detected  but  not 
necessarily  quantitated  as  an  exact  value.
21  Limit  of 
detection can be calculated using following equation as 
per ICH guidelines.  
LOD = 3.3 × N/S 
Where, N is the standard deviation of the peak areas of 
the  drug  and  S  is  the  slope  of  the  corresponding 
calibration curve.  
 
Limit of Quantification 
The  quantitation  limit  of  an  individual  analytical 
procedure is the lowest amount of analyte in a sample 
which  can  be  quantitatively  determined  with  suitable 
precision  and  accuracy.  The  quantitation  limit  is  a 
parameter  of  quantitative  assays  for  low  levels  of 
compounds in sample matrices, and is used particularly 
for the determination of impurities and/or degradation 
products
21.  Limit  of  quantification  can  be  calculated 
using following equation as per ICH guidelines.  
LOQ = 10 × N/S 
Where, N is the standard deviation of the peak areas of 
the  drug  and  S  is  the  slope  of  the  corresponding 
calibration curve.  
 
Results  
The absorbance of the EPE and PAR was measured at 
255  nm  and  249  nm  (Figure  3)  respectively  and 
calibration curves were plotted as concentrations versus 
absorbance.  The  Relative  Standard  Deviation  (RSD) 
for intra-day analysis of EPE was found in the range of 
0.58- 1.14 % (249 nm) and 0.69-1.44 % (260 nm), RSD 
for  Inter-day  analysis  of  EPE  was  found  to  be  0.47-
1.37% (249 nm) and 0.46-1.03% (260 nm). The RSD 
for intra-day analysis of PAR was found in the range of 
0.39-1.08% (249 nm) and 0.37-1.24% (260 nm), RSD 
for Inter-day analysis of PAR was found to be 0.64-
1.23%  (249  nm)  and  0.68-1.10%  (260  nm).  The 
accuracy and reproducibility is evident from the data as 
results are close to 100 % and the value of standard 
deviation and % R.S.D. were found to be < 2 %; shows 
the high precision of the method. The proposed method 
is  simple,  economical,  rapid,  precise  and  accurate. 
Hence it can be used for routine analysis of EPE and 
PAR  in  pharmaceutical  formulation.  The  proposed 
method  was  found  to  be  specific  as  there  is  no 
interference from other excipients. The LOD for EPE 
and PAR was found to be 0.12 μg/mL and 0.10 μg/mL 
respectively at 249 nm, LOD for EPE and PAR was 
found to be 0.13 μg/mL and 0.11 μg/mL respectively at 
260 nm. The LOQ for EPE and PAR was found to be 
0.41 μg/mL and 0.32 μg/mL respectively at 249 nm, 
LOQ for EPE and PAR was found to be 0.38 μg/mL 
and  0.34  μg/mL  respectively  at  260  nm.  Marketed 
brand  of  tablet  (Myosone  plus)  was  analyzed,  the 
amounts  of  EPE  and  PAR  determined  by  proposed 
method  were  found  to  be  100.28%  and  99.89% 
respectively. 
 
 
Figure 3. Absorption spectra of standard PAR at 10 μg/mL 
(Top) and EPE at 25 μg/mL (bottom). 
 
Discussion 
In  absorbance  ratio  method  (Q-analysis),  the  primary 
requirement  for  developing  a  method  for  analysis  is 
that the entire spectra should follow the Beer’s law at 
all the wavelength, which was fulfilled in case of both 
these  drugs.  The  two  wavelengths  were  used  for  the 
analysis  of  the  drugs  were  260  nm  (iso-absorptive 
point)  and  249  nm  (λ-max  of  PAR)  at  which  the 
calibration curves were prepared for both the drugs. In 
methanol,  EPE  and  PAR  obeyed  linearity  in  the 
concentration  range  of  5-25  μg/mL  and  2-10  μg/mL 
respectively  at  their  respective  λmax  with  correlation 
coefficient  (r
2  >  0.99)  in  both  the  case.  In  proposed 
method  precision  was  studied  as  repeatability 
(%RSD<2)  and  inter  and  intra-day  variations 
(%RSD<2) for both drugs; shows the high precision of 
the  method  (Table  1).  The  accuracy  of  method  was 
determined by calculating mean percentage recovery. It 
was determined at 50, 100 and 150 % level and data are 
presented in Table 2. The ruggedness of the methods 
was studied by two different analysts using the same 
operational  and  environmental  conditions.  The 
developed method for estimation of EPE and PAR in 
tablet dosage form was found to be simple, accurate, 
reproducible,  sensitive  and  economic.  For  projected 
method we used easily available and cheap solvent like 
methanol  (AR  grade),  Q  analysis  method  of 
simultaneous  estimation  not  required  any  expensive 
and  satisfactory  apparatus  in  contrast  to  reported 
chromatographic  and  hyphenated  techniques.  So  it 
shows proposed method is simple, economic and rapid 
for estimation  of  EPE  and  PAR  in  combined  dosage 
forms. Hence the developed method for estimation of 
EPE  and  PAR  can  be  constructive  in  the  routine 
analysis. 
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Table 1. Optical, Regression characteristics and validation parameters of Q-Absorbance ratio method for analysis of EPE and PAR. 
Parameters 
EPE  PAR 
249  260  249  260 
Beer’s Law Limit (μg/mL)  5-25  5-25  2-10  2-10 
Molar Absorptivity (1mole
-1cm
-1)  0.08044  0.085254  0.11036  0.078079 
Regression equation (y= mx + c)  
Slope (m)  0.097  0.093  0.067  0.039 
Intercept (c)  0.005  0.052  0.042  0.061 
Correlation Coefficient (r
2)  0.994  0.991  0.994  0.992 
Standard Deviation (S.D)  0.0027  0.0036  0.0047  0.0077 
Relative Standard Deviation (RSD or % CV)  0.7461  0.9145  0.6124  0.8345 
LOD (μg/mL)  0.12  0.13  0.10  0.11 
LOQ (μg/mL)  0.41  0.38  0.32  0.34 
Precision (%RSD) (n=5) 
Intraday  0.58-1.14  0.69-1.44  0.39-1.08  0.37-1.24 
Interday  0.47-1.37  0.46-1.03  0.64-1.23  0.68-1.10 
 
Conclusion 
The  developed  and  validated  UV  estimation  method 
reported here is rapid, simple, accurate, sensitive and 
specific.  The  method  was  also  successfully  used  for 
quantitative estimation and analysis of EPE and PAR in 
combined dosage form. Thus the reported method is of 
substantial  importance  and  has  great  industrial 
applicability  for  quality  control  and  analysis  of  EPE 
and  PAR  in  combined  dosage  forms.  By  observing 
validation parameter and statistical data, the proposed 
method was found to be satisfactory over other reported 
chromatographic methods. 
 
Table 2. Recovery studies of EPE and PAR. 
Drug 
Conc. of drug added 
%Recovery ±S.D.* 
μg/mL  %Level 
EPE 
5  50  100.55±0.65 
10  100  99.76±0.56 
15  150  101.43±0.26 
PAR 
5  50  99.37±0.34 
10  100  100.72±0.65 
15  150  99.46±0.49 
*Mean of three determinations 
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